Database Query Results : Bicalutamide, ,
Bical, Bicalutamide: Click to Expand ⟱
| Features: |
Bicalutamide brand name Casodex. An antiandrogen medication that is primarily used to treat prostate cancer.
|
Scientific Papers found: Click to Expand⟱
Dose↝, Remission↑,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
NA, |
DU145 |
|
|
|
- |
in-vitro, |
NA, |
LNCaP |
|
|
|
p‑ERK↑, p‑JNK↓, MUC1↓, p65↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
p‑JNK↓, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↑, 1,
Migration ⓘ
MUC1↓, 1,
Immune & Inflammatory Signaling ⓘ
p65↓, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1,
Functional Outcomes ⓘ
Remission↑, 1,
Total Targets: 6
Pathway results for Effect on Normal Cells:
Total Targets: 0
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:186 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page